| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. | Cancer Res | 2016 | 0.80 |
| 2 | Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. | Oncotarget | 2016 | 0.75 |